Oscar Health Insurance: What Lies Ahead for a Unicorn Insurance Entrant? Custom Case Solution & Analysis

Evidence Brief

Financial Metrics

Net Income Losses: 27.5 million dollars in 2014; 105.2 million dollars in 2015; 204.9 million dollars in 2016. (Exhibit 1)
Premium Revenue: 720.5 million dollars total across 2014 through 2016. (Exhibit 1)
Medical Loss Ratio: Exceeded 100 percent in initial years in New York and New Jersey markets. (Paragraph 12)
Marketing Spend: Roughly 20 million dollars annually in the New York City region. (Paragraph 15)
Valuation: 2.7 billion dollars as of the 2016 funding round. (Paragraph 4)

Operational Facts

Membership: 140000 members across New York, New Jersey, California, and Texas in 2016. (Paragraph 8)
Service Model: Concierge teams consisting of one nurse and five care guides per segment of members. (Paragraph 22)
Network Strategy: Transitioned from broad networks to narrow networks in New York to control costs. (Paragraph 18)
Technology: Integrated full-stack platform for claims processing and member engagement. (Paragraph 20)
Telemedicine: Free 24/7 access for all members; used by approximately 25 percent of the base. (Paragraph 21)

Stakeholder Positions

Mario Schlosser: CEO and Co-founder. Maintains that technology reduces long-term medical costs through engagement. (Paragraph 5)
Josh Kushner: Co-founder and Lead Investor via Thrive Capital. Views insurance as a data problem. (Paragraph 6)
Incumbent Insurers: UnitedHealth and Aetna. Withdrawing from ACA exchanges due to volatility and high risk pools. (Paragraph 25)
State Regulators: Focused on solvency and network adequacy as Oscar shifts to narrow provider sets. (Paragraph 28)

Information Gaps

Specific churn rates for members transitioning from year one to year two.
Detailed breakdown of Administrative Cost Ratio compared to industry incumbents.
Actuarial assumptions regarding the risk adjustment transfer payments for 2017.

Strategic Analysis

Core Strategic Question

Can Oscar transform its technology-driven member engagement into a sustainable cost advantage before its venture capital reserves are exhausted?

Structural Analysis

The individual insurance market under the Affordable Care Act (ACA) is characterized by high adverse selection and price sensitivity. Using the Value Chain lens, the primary challenge for Oscar is that its primary differentiation—user experience and technology—sits in the administrative and marketing layers, while 85 percent of costs reside in medical claims. Until the technology influences clinical outcomes or provider pricing, the firm remains a high-cost operator in a commodity market.

Strategic Options

Option 1: Pivot to Technology Licensing (SaaS)
Transition from a risk-bearing insurer to a technology provider for legacy carriers. This removes the burden of statutory capital requirements and medical risk. Trade-off: Loss of direct member data and lower revenue ceiling. Requirements: Modularization of the internal claims and engagement stack.

Option 2: Aggressive Expansion into Medicare Advantage (MA)
Shift focus from the volatile individual exchange to the stable, higher-margin MA segment. MA members have higher retention and value the concierge model. Trade-off: High regulatory barriers and intense competition from incumbents with deep provider ties. Requirements: Significant investment in specialized sales forces and star-rating management.

Option 3: Deep Vertical Integration
Acquire or build primary care clinics in key narrow-network hubs to capture the full margin and control the clinical path. Trade-off: Extremely capital intensive and limits geographic flexibility. Requirements: Physical infrastructure and clinical management talent.

Preliminary Recommendation

Oscar should pursue Option 2 (Medicare Advantage) while beginning the modularization required for Option 1. The individual exchange is a structural trap with low loyalty. Medicare Advantage rewards the high-touch engagement model Oscar has built, allowing for better risk-adjustment capture and lower churn. This path aligns the technology investment with the most profitable segment of the US health market.

Implementation Roadmap

Critical Path

Month 1-3: File for Medicare Advantage licenses in core markets (New York, Texas) to meet federal deadlines.
Month 1-4: Renegotiate narrow-network contracts with hospital systems to include MA-specific reimbursement tiers.
Month 4-6: Reconfigure the concierge team training to focus on chronic disease management and Medicare compliance.
Month 6-9: Launch targeted enrollment campaign for the Annual Enrollment Period.

Key Constraints

Capital Reserves: Current burn rates on the individual exchange limit the runway for the high customer acquisition costs associated with Medicare.
Provider Resistance: Narrow networks only work if providers see volume; incumbents may block access to top-tier systems.
Regulatory Scrutiny: Medicare Advantage has stricter network adequacy and compliance standards than the individual exchange.

Risk-Adjusted Implementation Strategy

To mitigate the risk of a botched MA entry, Oscar must exit the least profitable ACA markets (e.g., New Jersey) to preserve 150 million dollars in capital. The expansion should be limited to two high-density urban zones where the current concierge teams have established provider relationships. Contingency: If enrollment hits less than 60 percent of the target in year one, the firm must immediately pivot to Option 1 (Licensing) to avoid insolvency.

Executive Review and BLUF

BLUF

Oscar Health is a technology company mispriced as an insurance company. The current path on the individual exchange is unsustainable; the medical loss ratios and capital requirements will lead to a liquidity crisis within 24 months. The firm must pivot to Medicare Advantage where its engagement model generates actual margin, or exit risk-bearing entirely to become a software vendor. Success requires immediate withdrawal from underperforming markets to protect the remaining balance sheet.

Dangerous Assumption

The analysis assumes that high member engagement through an app directly correlates to lower medical utilization. There is no evidence in the case that a 25 percent telemedicine adoption rate is sufficient to offset the high cost of the sickest members in the individual risk pool.

Unaddressed Risks

Regulatory Volatility: Changes to ACA risk-adjustment formulas could result in massive, unpredictable payments to competitors, wiping out cash reserves regardless of operational performance. (Probability: High; Consequence: Critical)
Incumbent Response: UnitedHealth and Cigna have significantly more data and can replicate the user interface features of Oscar once the market viability is proven. (Probability: Medium; Consequence: High)

Unconsidered Alternative

The team failed to consider a White Label partnership with a regional health system. Oscar could provide the technology and brand while the health system carries the insurance risk and provides the clinical care. This would allow Oscar to scale without the 100 million dollar plus annual losses associated with underwriting.